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Royal College Street, London, NW1 0TU, U.K.History of the STR/ort Mouse
The parent STR/1N strain was isolated by Dr George E.
Jay, Jr in 1951 as a spontaneous piebald (white and
red/brown) mutant of STR/1N arising in the F29
generation1. STR/ort mice were derived from the parent
STR/1N strain following a period of non-inbreeding. After
initiating inbreeding again they were designated as the
sub-strain STR/ort2.85Morphological studies
In our experience, degeneration of the cartilage in the
STR/ort strain occurs first at the interface of the cruciate
ligament and the medial tibial articular cartilage and, as in
the STR/1N strain, the histological lesions closely resemble
those of human OA18 (Fig. 1). Lesions develop in the
medial plateau and range in severity from mild erosion of
the cartilage surface to complete loss of the tissue and
exposure of the subchondral bone18. We have used a
six-point grading system to describe the severity of
osteoarthritic lesions in the STR/ort mouse19.
Schunke et al. described the histopathological charac-
teristics of osteoarthritic cartilage lesions in the knee joint of
male STR/1N mice20. The lesion first appeared on the
medial tibial plateau and as the disease progressed there
was a loss of cartilage which resulted in a pronounced
instability of the knee joint and a varus deformity. This was
followed by medial patellar subluxation. The authors con-
cluded that cartilage degeneration in the medial tibial
condyle develops spontaneously due to an unknown patho-
genesis and it is this event that is responsible for secondary
patellar subluxation. This conclusion was supported by the
findings of Dreessen and Halata21 who showed an age-
related osteoarthritic degeneration in the tempero-
mandibular joint (TMJ) of male STR/1N mice, suggestive of
a systemic basis of the disease.
Walton22 surgically stabilized the patellae on the left legs
of young male STR/ort mice and used the right legs as
controls. None of the nine stabilized knee joints had histo-
logical signs of OA, whereas the control legs showed a
normal range of joint damage. Walton concluded that
patella subluxation was the primary cause of OA in the
STR/ort mouse. Nevertheless, of 59 STR/ort mice with OA
(grades 1–4), 19 had normal patellae, which does not
accord with this conclusion. In a more recent report, Evans
et al.23 made a radiological assessment of OA progression
in the knee and ankle joints of the STR/ort mouse. TheReceived 8 March 2000; accepted 25 March 2000.
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In a series of papers, Silberberg and Silberberg
presented evidence that the development of osteoarthritis
(OA) in mice is influenced by a variety of nutritional and
hormonal factors3–10. In a survey of 18 mouse strains,
Sokoloff and Jay11 reported that the highest incidence of
naturally-occurring OA occurred in strain STR/1N. Overall,
male mice had a higher incidence of degenerative
joint disease than female mice and the medial condyles
were affected to a much greater degree than the lateral
condyles12. However, in a pilot study of ovarectomized,
castrated, and sham-operated STR/ort mice of both sexes,
we found no evidence to suggest that the development of
OA was dependent on sex hormones in this model13. In a
study of the genetics of degenerative joint disease in mice,
including STR/1N, the disease was shown to be polygenic
with indications of recessive inheritance, but there was no
evidence of sex linkage14.
Another characteristic of the STR/1N strain is
spontaneous obesity, even while receiving a standard diet.
Like the STR/1N mice, the STR/ort mice have a high body
weight compared to other laboratory strains14,15. Both
STR/ort sexes grow at a faster rate and they reach a peak
of growth 3 months before their CBA counterparts2.STR/1N mice also have increased susceptibility to perio-
dontal disease16, a high incidence of hepatomas, and a low
level of hemoglobin14. Both STR/1N and STR/ort mice
have an increased incidence of obstructive ureteric disease
and in the STR/1N strain this could be prevented by
castration1,17.
86 R. M. Mason et al.: Osteoarthritis in STR/ort miceFig. 1. Medial tibial cartilage of male STR/ort mice stained with Alcian blue (AB) showing varying stages of histological OA. (a) Normal
cartilage with smooth surface and uniform AB matrix staining. (b) Early OA with loss of AB stain and small surface lesion (↓). (c) Advancing
OA with marked loss of AB staining and extensive surface roughening and fibrillation. (d) Severe OA with loss of AB staining and loss of
articular cartilage down to the subchondral bone (↓). Original magnification ×10.results failed to support Walton’s contention that patella
displacement was the primary event in the development of
OA in this strain. However, it is of interest that Evans et al.23
reported that soft tissue calcification may be an earlier
event than cartilage erosion, a finding that was substanti-
ated by a further report24. Walton also noted soft tissue
calcification25. In our experience the degree of calcification
in these structures varies between STR/ort colonies main-
tained in different institutes. Local environmental changes
may account for these differences. Our colony has only a
low level of calcification in the periarticular tissues. Soft
tissue changes may also occur in the absence of calcifica-
tion. Anderson-Mackenzie et al. noted decreased strength
of the anterior cruciate ligament and increased collagen
remodelling before any radiological evidence of OA in the
STR/ort knee joint26. Thus, while it seems unlikely that
subluxation of the patella is the primary factor inducing OA,
it cannot be ruled out that changes in soft tissues in or
around the knee destabilize the joint and induce changes in
the tibial cartilage.
Walton15 also investigated whether obesity was an
etiological factor in the development of OA in STR/ort mice.
He concluded that there was no positive correlation
between obesity and OA. We also found no correlation
between the weight and severity of OA in individual STR/ort
mice (Fig. 2) and Sokoloff et al. reported genetic dissocia-
tion between obesity and susceptibility to OA in the STR/1N
strain14. Figure 2 also draws attention to two other features
of OA in STR/ort mice. First, mild histopathological lesions
are often evident in one or other knee joint at 10 weeks of
age. Occasionally these are severe. By 20 weeks most
animals have lesions in one or both knees, but it is clear
that the age of onset and the severity of lesions is quite
variable between different mice. Second, the medial tibial
cartilage is generally affected while the lateral is usually
spared, or only mildly affected, as in some other murine OA
of the knee joint12. Male STR/ort mice are also known todevelop a spontaneous ankle deformity, but it was reported
that there was no correlation between this and the
presence of OA27.
Das-Gupta et al.28 described a histological evaluation of
the patello-femoral joints of 37 male STR/ort mice and
reported the presence of an acute and chronic synovial
inflammatory infiltrate. However, Collins et al.24 found no
significant inflammatory changes in the synovial tissue and
no alteration in the sub-synovial tissue was detected in
animals with established OA. Likewise our own observa-
tions over several years have not detected significant
synovial inflammatory infiltrates in the STR/ort mouse. It
is likely that the particular STR/ort colony studied by
Das-Gupta et al. was atypical and that the findings
described by these authors are not a universal feature of
the strain.Cytochemical studies
CHONDROCYTE METABOLISM
Chondrocytes depend on anerobic respiration for the
re-oxidation of NADH generated during glycolysis. Apart
from its requirement in glycolysis, NAD is also required as
a co-enzyme for two oxidative reactions involved in the
biosynthesis of UDP-sugars needed for glycosaminogly-
can synthesis. Histochemical studies by Altman29 sug-
gested a deficiency of lactate dehydrogenase activity in
chondrocytes of the medial tibial cartilage of STR/ort
mice. This occurred before any histological evidence of
degeneration. He proposed that this would lead to
increased levels of NADH in chondrocytes which would
compromise glycolysis and glycosaminoglycan synthesis.
Studies by Dunham et al.30 indicated a decline in
glucose-6-phosphate dehydrogenase (G6PD) activity with
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Fig. 2. Severity of OA lesions in the tibial plateau in relation to age and body weight of male STR/ort mice. Data are shown for the medial
and lateral tibial cartilage of the right and left knee. Body weight, dark shaded bars; OA grade, light shaded bars. Grade 0, normal; 1,
roughened articular surface and small fibrillations; 2, fibrillation down to the layer immediately below the superficial layer (zone 2) and some
loss of surface lamina; 3, loss of surface lamina and fibrillations extending down to the calcified cartilage; 4, major fibrillations and cartilage
erosion down to subchondral bone; 5, major fibrillations and erosion of up to 80% of the cartilage; 6, greater than 80% loss of cartilage.age in the medial tibial plateau of STR/ort mice. They
surmised that this too contributed to the development of
OA.5′-Nucleotidease, an enzyme on the purine degradation
pathway converting inosine 5′ phosphate to inosine, is
normally expressed in the superficial zone of murine
88 R. M. Mason et al.: Osteoarthritis in STR/ort miceFig. 3. Aggrecan cleavage neoepitopes in OA medial cartilage of STR/ort mice. (a) Neutral matrix metalloproteinase-generated neoepitope
(VDIPEN); (b) aggrecanase-generated neoepitope (NITEGE). AC=articular cartilage.articular cartilage. In the STR/ort mouse enzyme activity is
markedly increased in cells adjacent to a lesion throughout
the full cartilage depth31. The chondrocytes in the area of
the lesion also show other changes. For example, in-situ
hybridization studies indicate an absence of aggrecan
transcripts in these cells32. Moreover, cytochemical assays
for activity of UDP-glucose dehydrogenase, a key enzyme
in generating UDP-glucuronate for chondroitin sulfate syn-
thesis, show a marked reduction in the chondrocytes close
to the lesions (unpublished results). These findings, taken
together, indicate that aggrecan synthesis in these cells is
likely to be severely compromised, contributing to the
matrix proteoglycan depletion in the same area which is
detected by Alcian blue staining. Chondrocytes in the
lesional area may have generally low levels of metabolic
activity since the TUNEL assay suggests that many of them
are undergoing apoptosis. Indeed, we have shown that
there is a linear correlation between the number of TUNEL
positive cells in this area and the severity of the osteo-
arthritic lesion33. Electron microscopy confirms the
apoptotic nature of these cells which have morphological
features identical to those reported by Hashimoto et al. for
apoptotic chondrocytes34. Interestingly, the distribution of
monoamine oxidase, an enzyme normally localized to
mitochondria, is changed in the medial tibial cartilage of
STR/ort mice where activity was detected in the extracel-
lular matrix35. One possible explanation is enzyme leakage
from apoptotic chondrocytes.Biochemical and molecular studies
Dunham et al.42 showed that the birefringence of Alcian
blue stained proteoglycans in the medial tibial cartilage of
the STR/ort mouse declined as the severity of the disease
increased. This suggested progressive disorganization of
the proteoglycans which, together with a dysfunctional
collagen network, would contribute to the altered bio-
chemistry and physicochemical properties characteristic of
osteoarthritic cartilage. Biochemical investigation of indi-
vidual tibial plateau of mice is extremely difficult. However,CARTILAGE DEGRADATION
Chambers et al.19 investigated whether there were
changes in the expression of systemic factors which are
known to influence matrix catabolism. Analysis of gene
expression for IL-1 and -, IL-6, IGF-1 and TGF showed
that transcripts for all were present in the STR/ort chondro-
cytes. However, they could not be detected in the age- and
sex-matched control CBA mice. Furthermore, anabolic
growth factors predominated in pre-lesion cartilage,
whereas catabolic cytokines were more strongly expressed
in the later stages of the disease. These findings are
consistent with a disease mechanism in which the chondro-
cyte is primed to increase the synthesis of matrix macro-
molecules prior to the appearance of the tissue lesion. This
response ultimately fails and cartilage erosion follows. The
cytokine changes would be expected to induce proteinasesresponsible for matrix degradation. An in-situ hybridization
study36 showed that collagenase 3 expression is increased
in normal areas of STR/ort tibial cartilage compared to
age-matched CBA mice which do not develop OA. How-
ever, collagenase 3 expression is frequently lost in STR/ort
chondrocytes adjacent to osteoarthritic lesions. We also
investigated collagenase 3 in STR/ort tibial chondrocytes
by immunohistochemistry following incubation of the knee
joint in a medium containing monensin to block secretion of
the enzyme from cells. However, even with this method the
enzyme was not consistently detected in STR/ort chondro-
cytes in all animals tested36. Nevertheless, it should be
noted that a study carried out by Brewster et al.37 indicated
that tibial cartilage degeneration in the STR/ort mouse
could be inhibited with a selective collagenase inhibitor. It
should be noted that some other proteases can also cleave
the triple helical region of collagens. We also examined
whether collagen cleavage neoepitopes are generated in
STR/ort tibial cartilage using the Col 2-3/4C short antibody
which detects such cleavage38. Such neoepitopes appear
only when cartilage fibrillations are present39.
The degradation of aggrecan in STR/ort tibial cartilage
was mapped by Chambers et al., using anti-sera which
recognized the neoepitopes generated by proteolytic
enzymes cleaving the molecule between amino-acid resi-
dues Asn341-Phe342 [metalloproteinase(s)] and Glu373-
Ala374 [aggrecanase (ADAMTS)]40. Both of these
fragments were detected in tibial cartilage of CBA and
STR/ort mice41. In some areas the localization overlapped,
suggesting that the enzymes may act together as well
as independently (Fig. 3). Immunostaining of the matrix
adjacent to the cartilage lesion suggested that MMPs and
aggrecanase may have been released into the matrix,
promoting tissue degradation.
Osteoarthritis and Cartilage Vol. 9, No. 2 89Rostand et al.43,44 used the Beckman-Airfuge to isolate
and characterize articular cartilage proteoglycans from the
STR/1N mouse. No qualitative changes in the structure of
aggrecan were observed in the diseased animals. How-
ever, these authors found that a greater proportion of
35S-labeled proteoglycans were extractable from the carti-
lage of OA mice than from normal mice, suggesting that the
restraining collagen network may have been disrupted in
the former. More recent work showed that the chondroitin
sulfate content of the tibial plateau cartilage was elevated in
the 18- to 20-week STR/ort mouse45. Similar findings were
also reported by Collins et al.24 for the proteoglycan con-
tent of the STR/ort patellae. Gaffen et al.46 used quantita-
tive RT-PCR to measure aggrecan mRNA levels in the tibial
cartilage of 18- to 20-week male STR/ort mice and showed
that they were higher than those in CBA control mice. This
and the elevated concentration of chondroitin sulfate in
the cartilage at this age suggest that matrix synthesis is
stimulated at this stage of the disease. The 4-sulfated
isomer of chondroitin sulfate was dominant at all ages in
both the STR/ort and CBA articular cartilage45. It was
shown that the osteoarthritic mice synthesized a normal
spectrum of proteoglycans and that most of them were
aggrecan46.
Initial comparative studies of two different colonies of
STR/ort mice suggested that one developed more severe
osteoarthritic lesions than the other47. However, genetic
fingerprint analysis showed a high degree of homogeneity
both within and between the two colonies. Moreover, a
more extensive analysis showed that the colonies did not in
fact differ in the rate at which they developed the disease or
the severity of lesions which developed. Rather, the find-
ings indicate that there is a marked range in the severity of
lesions found in any one group of STR/ort mice at any one
age. Clearly this is a factor which must be taken into
account in any study of disease-modifying agents in these
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The STR/ort strain of mouse is an acceptable animal
model for studying the development of OA. The disease isa naturally occurring one. About 85% of all male mice
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